Zhiwei Gao, Ph.D. - Publications

Affiliations: 
2012 HKUST Hong Kong University of Science and Technology (Hong Kong) 
Area:
Civil Engineering, Materials Science Engineering

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sun J, Xu W, Hua H, Xiao Y, Chen X, Gao Z, Li S, Jing X, Du F, Sun G. Pharmacodynamic and pharmacokinetic effects of S086, a novel angiotensin receptor neprilysin inhibitor. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 129: 110410. PMID 32570118 DOI: 10.1016/j.biopha.2020.110410  0.48
2019 Zhang L, Mao Y, Gao Z, Chen X, Li X, Liu Y, Xia G. The Nonclinical Pharmacokinetics and Prediction of Human Pharmacokinetics of SPH3127, a Novel Direct Renin Inhibitor. European Journal of Drug Metabolism and Pharmacokinetics. PMID 31494843 DOI: 10.1007/s13318-019-00573-9  0.48
2019 Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu H, Ni T, Zhang ZS, Zhang T, Li C, Han L, Zhu Z, Lian F, Wei J, Deng Q, ... ... Gao Z, et al. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia. Cancer Cell. 35: 677-691.e10. PMID 30991027 DOI: 10.1016/j.ccell.2019.03.006  0.48
2016 Guo ZQ, Zheng T, Chen B, Luo C, Ouyang S, Gong S, Li J, Mao LL, Lian F, Yang Y, Huang Y, Li L, Lu J, Zhang B, Zhou L, ... ... Gao Z, et al. Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer. Cancer Cell. 30: 474-484. PMID 27622336 DOI: 10.1016/j.ccell.2016.08.003  0.48
2016 Yu M, Gao Z, Dai X, Gong H, Zhang L, Chen X, Zhong DF, Sy SK. Population Pharmacokinetic and Covariate Analysis of Apatinib, an Oral Tyrosine Kinase Inhibitor, in Healthy Volunteers and Patients with Solid Tumors. Clinical Pharmacokinetics. PMID 27379402 DOI: 10.1007/s40262-016-0427-y  0.36
2016 Sun W, Shi L, Ye Z, Mu Y, Liu C, Zhao J, Chen L, Li Q, Yang T, Yan L, Wan Q, Wu S, Liu Y, Wang G, Luo Z, ... ... Gao Z, et al. Association between the change in body mass index from early adulthood to midlife and subsequent type 2 diabetes mellitus. Obesity (Silver Spring, Md.). PMID 26833544 DOI: 10.1002/oby.21336  0.36
2015 Li C, Ai J, Zhang D, Peng X, Chen X, Gao Z, Su Y, Zhu W, Ji Y, Chen X, Geng M, Liu H. Design, Synthesis, and Biological Evaluation of Novel Imidazo[1,2-a]pyridine Derivatives as Potent c-Met Inhibitors. Acs Medicinal Chemistry Letters. 6: 507-12. PMID 26005523 DOI: 10.1021/ml5004876  0.48
2015 Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, Wang J, Li Y, Chen W, Song B, Wang F, Jia Z, Li L, Li Y, Yang B, ... ... Gao Z, et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. American Journal of Human Genetics. 96: 597-611. PMID 25839328 DOI: 10.1016/j.ajhg.2015.02.017  0.48
2014 Zhong K, Gao Z, Li Q, Zhong D, Chen X. A chiral high-performance liquid chromatography-tandem mass spectrometry method for the stereospecific determination of morinidazole in human plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 961: 49-55. PMID 24858695 DOI: 10.1016/j.jchromb.2014.04.049  0.36
2014 Lin L, Xie C, Gao Z, Chen X, Zhong D. Metabolism and pharmacokinetics of allitinib in cancer patients: the roles of cytochrome P450s and epoxide hydrolase in its biotransformation. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 872-84. PMID 24598282 DOI: 10.1124/dmd.113.056341  0.48
2013 Lin L, Gao Z, Chen X, Zhong D. Development and validation of a sensitive LC-MS/MS assay for the simultaneous quantification of allitinib and its two metabolites in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 86: 49-55. PMID 23973791 DOI: 10.1016/j.jpba.2013.07.003  0.48
2013 Ding J, Chen X, Gao Z, Dai X, Li L, Xie C, Jiang H, Zhang L, Zhong D. Metabolism and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor apatinib in humans. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 1195-210. PMID 23509226 DOI: 10.1124/dmd.112.050310  0.48
2013 Xie C, Zhou J, Guo Z, Diao X, Gao Z, Zhong D, Jiang H, Zhang L, Chen X. Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients. British Journal of Pharmacology. 168: 1687-706. PMID 23126373 DOI: 10.1111/bph.12047  0.48
Show low-probability matches.